Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance

Katrine Sonne-Hansen, Ida C Norrie, Kristina Bennet Emdal, Rikke Vicki Benjaminsen, Thomas Frogne, Ib J Christiansen, Tove Kirkegaard, Anne E Lykkesfeldt

    26 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Breast cancer cells can switch between estrogen receptor alpha and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance'. Together they form a unique fingerprint.

    Medicine & Life Sciences